集采的深化正以不可逆之势重塑医疗设备行业格局，价格博弈加剧、市场份额重新划分，裁员、退出、降本增效等消息接踵而至，行业 “凛冬” 的论调渐起，不少企业在政策与市场的双重压力下举步维艰。但寒冬之下，亦是格局重构的关键窗口期——国产品牌能否穿越政策周期，在成本与创新的平衡中突围？又有哪些企业能凭借技术沉淀、全球化布局与差异化策略逆势而上，从 “价格战” 走向 “价值战”？01—集采3.0：从“唯低价”...
Source Link集采的深化正以不可逆之势重塑医疗设备行业格局，价格博弈加剧、市场份额重新划分，裁员、退出、降本增效等消息接踵而至，行业 “凛冬” 的论调渐起，不少企业在政策与市场的双重压力下举步维艰。但寒冬之下，亦是格局重构的关键窗口期——国产品牌能否穿越政策周期，在成本与创新的平衡中突围？又有哪些企业能凭借技术沉淀、全球化布局与差异化策略逆势而上，从 “价格战” 走向 “价值战”？01—集采3.0：从“唯低价”...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.